Sort
15,842 grants matching “pancreatic cancer”
Targeting Lymph Node Dependent Immune Tolerance in Cancer
$531,707Edgar G. Engleman · Stanford University · R01 · FY2021 · CA
CA140228: PANCREATIC CANCER'S DESMOPLASIA: THE POSSIBLE BRIDGE IMPENDING NERVE INFILTRATION AND NEOPLASTIC ESCAPE
$531,685The Institute For Cancer Research · · FY2015 · Department of Defense
Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer
$531,608Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2023 · CA
Sialylation-dependent mechanisms driving pancreatic cancer progression
$531,574Susan L Bellis · University Of Alabama At Birmingham · U01 · FY2020 · CA
Biospecimen Acquisition, Processing and Classification Unit
$531,549Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · U2C · FY2019 · CA
Project 1: Physical modeling and dynamics of tumor cell migration mechanics
$531,383David J Odde · University Of Minnesota · U54 · FY2020 · CA
Interrogation of the Impact of Selection on the Evolution of Human Pancreatic Cancer Precursor Lesions
$531,077Laura Delong Wood · Johns Hopkins University · U01 · FY2023 · CA
HHSN2612012000131/HHSN26100010Base Contract Title: Preclinical Efficacy and Intermediate Endpoint Biomarkers. Task Order Title: Preclinical Studies to Evaluate the Combination of Metformin and As
$530,889Chinthalapally Rao · · N01 · FY2014 · CA
Case Control Study of Pancreas Cancer in Shanghai, China
$530,641Harvey A Risch · Yale University · R01 · FY2008 · CA
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
$530,360Elizabeth Marion Jaffee · Johns Hopkins University · R01 · FY2024 · CA
Studies of Materials with Physiological Properties
$530,266Harvard University · R01 · FY2003 · GM
Mechanism by which ketogenic diet uncouples tumor growth and overall survival
$530,122Tobias Janowitz · Cold Spring Harbor Laboratory · R37 · FY2024 · CA
Detection of Pre-Invasive Pancreatic Cysts Using Protein and Glycan Biomarkers
$530,069Brian B Haab · Van Andel Research Institute · U01 · FY2013 · CA
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION
$530,030Anna Sf Lok · University Of Michigan At Ann Arbor · U01 · FY2021 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$529,878Nikhil Joshi · Yale University · R01 · FY2024 · CA
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
$529,533Chi V. Dang · Johns Hopkins University · R01 · FY2024 · CA
Screening for inhibitors of NSD3 as a treatment for lung cancer
$529,475Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure
$529,416Shyam Sharan · Division Of Basic Sciences - Nci · ZIG · FY2018 · CA
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
$529,313Andre Elias Nel · University Of California Los Angeles · R01 · FY2022 · CA
Nanovaccine platforms to combat pancreatic cancer
$529,150Balaji Narasimhan · Iowa State University · U01 · FY2019 · CA
Project 3-Cancer cell interaction with oncogenic type 1 collagen in PDAC
$529,109Raghu Kalluri · University Of Tx Md Anderson Can Ctr · P01 · FY2024 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$529,061David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Investigating the metastatic drive in pancreas cancer
$529,025Sunil R Hingorani · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications
$529,020Alan Ashworth · University Of California, San Francisco · R01 · FY2021 · CA
The role of collagen and its signaling mechanisms in glioma progression and invasion.
$529,012Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2022 · NS